A rare cutaneous infection in a chronic intra-muscular drug abuser
DOI:
https://doi.org/10.18203/2320-6012.ijrms20230594Keywords:
Cutaneous mucormycosis, Health care associated cutaneous infection, Opportunistic infectionAbstract
After rhinocerebral and pulmonary, mucormycosis affecting the skin is considered to be the third most common type of mucormycosis. It has varied presenting features and hence it is important to make a diagnosis early to achieve better outcomes. Although a large proportion of published cases have no underlying disease, it is most commonly associated with diabetes and blood malignancies. The mode of infection is usually due to cutaneous trauma, while the rest of the cases are health-care associated. Apophysomyces spp are usually seen in Asia, while Rhizopus is the most common genus in Europe, North America and South America. It is usually treated with antifungals like amphotericin B and/or surgery. In this article, we presented a case of a middle aged immune-competent female with a history of recurrent intramuscular and intravenous drug usage presenting with cutaneous mucormycosis.
Metrics
References
Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi. 2019;5(1):26.
Skiada A, Drogari-Apiranthitou M, Pavleas I, Daikou E, Petrikkos G. Global Cutaneous Mucormycosis: A Systematic Review. J Fungi (Basel). 2022;8(2):194.
Pérez AD, Welsh EC, Miranda I, Ocampo-Candiani J, Welsh O. Cutaneous mucormycosis. An Bras Dermatol. 2017;92(3):304-11.
Madhumitha R, Jagadeesh C, Sharma AN, Nambi P, Gopalakrishnan R. Isolated renal mucormycosis in an apparently healthy immune competent adult. Int J Med Health Sci. 2017;6(2).
Kumar MMR, Jagadeesh C, Madhumitha R, Gopalkrishnan R. Ileal mucormycosis in an immunocompetent individual presenting as septic shock: One of its kind presentations. JMSCR. 2018;6(8).
Adam RD, Hunter G, DiTomasso J, Comerci G. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis. 1994;19(1):67-76.